InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,479.94
(
0.12%
)
US TECH 100
19,396.80
(
-0.03%
)
Dow Jones
38,763.08
(
-0.04%
)
Brent Oil
84.42
(
0.61%
)
Bitcoin
65,230.62
(
-1.89%
)
Post# of 252235
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119861
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 156463

Tuesday, 02/05/2013 1:12:54 PM

Tuesday, February 05, 2013 1:12:54 PM

Post# of 252235

GILD–I'm not even sure the 7% difference doesn't show stst-sig non inferiority to SOC.

The inferiority of the all-oral arm to the old SoC was non-statsig, according to yesterday's CC. Still, I agree with oc631 that Sofosbuvir + ribavirin for 12w doesn't cut it in genotype-3.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up